La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Crystal International Gr a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Crystal International Gr..

Crystal International Gr (OTC:CRYIF) Azioni, Catena delle Opzioni

Crystal International Group Ltd is principally engaged in the manufacturing and trading of garments. Its operating segments include Lifestyle wear, Denim, Intimate, Sweater, Sportswear, and Outdoor Apparel. It generates a majority of its revenue from Lifestyle wear. Geographically, it generates the majority of revenue from the Asia Pacific which includes Japan, China, Hong Kong, and South Korea.

CRYSTAL INTL GROUP LTD by Crystal International Group Ltd.

Crystal International Group Ltd

For the first quarter of 2025, the Company GAAP net loss is expected to be $1 million, compared to a net loss of $34.5 million in the first quarter of 2024. First quarter 2025 GAAP diluted loss per share is expected to be $0.05, compared to a diluted loss per share of $0.53 in the first quarter of 2024. First quarter 2025 adjusted EBITDA is expected to be $160 million or 5.9% of revenue, with adjusted diluted earnings per share expected to be $0.34.
 &nbsp;

News

Guidance

MasTec Expects Q1 Revenue Of $2.7B (Est $2.851B), Adjusted EPS Of $0.34 (Est $0.44)

Marvell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) has outperformed the market over the past 5 years by 18.43% on an annualized basis producing an average annual return of 32.7%. Currently, Marvell Tech has a market capitalization of $76.32 billion. 
Buying $100 In MRVL: If an investor had bought $100 of MRVL stock 5 years ago, it would be worth $399.13 today based on a price of $88.20 for MRVL at the time of writing.
<h3>Marvell Tech's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740694522_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

MRVL

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today

Structure Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GPCR#NASDAQ">GPCR</a>) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(0.80) by 2.5 percent. This is a 3.7 percent increase over losses of $(0.81) per share from the same period last year.

Earnings

GPCR

Structure Therapeutics FY 2024 GAAP EPS $(0.78) Beats $(0.80) Estimate

Issuing Initial Annual 2025 Guidance Including Revenue of $13.45 Billion, a 9% Increase Over 2024, GAAP Net Income of $327&nbsp;Million to $366 Million, Adjusted EBITDA of $1.10 Billion to $1.15 Billion, with Diluted Earnings Per Share of $3.75 to $4.24.
 &nbsp;

MasTec Expects FY25 Revenue Of $13.45B (Est $13.281B), Adjusted EPS Of $5.35 - $5.84 (Est $5.31)

Arcadium Lithium (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALTM#NYSE">ALTM</a>) reported quarterly earnings of $0.01 per share which met the analyst consensus estimate. This is a 97.06 percent decrease over earnings of $0.34 per share from the same period last year. The company reported quarterly sales of $289.00 million which beat the analyst consensus estimate of $269.06 million by 7.41 percent. This is a 58.79 percent increase over sales of $182.00 million the same period last year.

Earnings Beats

ALTM

CORRECTION: Arcadium Lithium Q4 Adj EPS $0.01, Inline, Sales $289.00M Beat $269.06M Estimate

Nelnet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NNI#NYSE">NNI</a>) reported quarterly earnings of $1.44 per share which beat the analyst consensus estimate of $1.23 by 17.07 percent. &nbsp;

Nelnet Q4 2024 Adj EPS $1.44 Beats $1.23 Estimate

DoubleVerify Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DV#NYSE">DV</a>) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.18 by 22.22 percent. This is a 26.32 percent decrease over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $190.62 million which missed the analyst consensus estimate of $196.89 million by 3.18 percent. This is a 10.68 percent increase over sales of $172.23 million the same period last year.

Earnings Misses

DoubleVerify Hldgs Q4 EPS $0.14 Misses $0.18 Estimate, Sales $190.62M Miss $196.89M Estimate

Implores UDF IV Board to Postpone March 4 Special Meeting for One Month to Engage with NexPoint and Appropriately Evaluate Proposal
NexPoint Will Not Vote at Special Meeting Without Due Consideration of Proposal
DALLAS, Feb. 27, 2025 /PRNewswire/ --&nbsp;NexPoint Advisors, L.P. (together with its affiliates "NexPoint") today announced NexPoint Real Estate Opportunities, LLC has submitted a competing proposal to the Board of Trustees of United Development Funding IV ("UDF IV" or "the Trust") ahead of the Special Meeting of UDF IV Shareholders (the "Meeting"), scheduled for&nbsp;March 4, 2025, to vote on the proposed merger of UDF IV with Ready Capital (NYSE:&nbsp;RC) (the "Ready Merger").
The confidential proposal submitted by NexPoint mirrors many elements of the Ready Merger but provides shareholders with superior economic terms, including enhanced balance sheet distributions, full entitlement to Contingent Value Rights ("CVR") loan proceeds, and potentially large indemnification reimbursements. Specifically, NexPoint's offer contemplates balance sheet distributions that it believes will provide shareholders with a higher pre-closing dividend than the Ready Merger. Shareholders would also receive 100% of the net principal and interest recovered on the CVR loans. By comparison, the Ready Merger entitles Ready Capital to 100% of the CVR loan proceeds until it has recovered $13.3 million net, and thereafter shareholders only receive credit for 60% of additional net recoveries, which UDF IV estimates to be as much as $20 million. Additionally, NexPoint proposes to cease further indemnification payments for the imprisoned management team and recipients of the improper indemnity payments associated with the SEC disgorgement and intends to recover those improperly advanced legal fees and indemnity payments, with 100% of net recoveries being distributed to shareholders.

Management

NXDT

NexPoint Urges UDF IV Board To Postpone March 4 Meeting, Calls For 1-Month Delay To Evaluate Superior Proposal; Offers Enhanced Distributions, Full CVR Share, And Indemnity Reimbursement; NexPoint Won't Vote Without Proper Consideration

HTCO

High-Trend International FY24 Total Revenue $108.2M, Up 13.6% YoY

Arcosa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACA#NYSE">ACA</a>) sees FY2025 sales of $2.800 billion-$3.000 billion vs $2.95 billion analyst estimate.

Arcosa Sees FY2025 Sales $2.800B-$3.000B vs $2.95B Est

Banco Latinoamericano (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLX#NYSE">BLX</a>) reported quarterly earnings of $1.40 per share. This is a 10.24 percent increase over earnings of $1.27 per share from the same period last year. The company reported $78.40 million in sales this quarter. This is a 0.77 percent increase over sales of $77.80 million the same period last year.

Banco Latinoamericano Q4 EPS $1.40 Up From $1.27 YoY, Sales $78.40M Up From $77.80M YoY

Arcosa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACA#NYSE">ACA</a>) reported quarterly earnings of $0.46 per share which missed the analyst consensus estimate of $0.76 by 39.47 percent. This is a 32.35 percent decrease over earnings of $0.68 per share from the same period last year. The company reported quarterly sales of $666.20 million which missed the analyst consensus estimate of $690.28 million by 3.49 percent. This is a 14.43 percent increase over sales of $582.20 million the same period last year.

Arcosa Q4 Adj $0.46 Misses $0.76 Estimate, Sales $666.20M Miss $690.28M Estimate

The Board of Directors of NewMarket Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEU#NYSE">NEU</a>) declared a quarterly dividend in the amount of $2.75 per share on the common stock of the Corporation, an increase of $0.25, or 10%, as compared to the last quarterly dividend of $2.50 per share. The dividend is payable April 1, 2025, to NewMarket shareholders of record at the close of business on March 17, 2025.

Dividends

NewMarket Corporation Increases Quarterly Dividend From $2.50 To $2.75 Per Share

Energous (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WATT#NASDAQ">WATT</a>) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.74) by 55.41 percent. This is a 55.41 percent increase over losses of $(0.74) per share from the same period last year. The company reported quarterly sales of $428.00 thousand which missed the analyst consensus estimate of $500.00 thousand by 14.40 percent. This is a 366.91 percent increase over sales of $91.67 thousand the same period last year.

WATT

Energous Q4 2024 Adj EPS $(0.33) Beats $(0.74) Estimate, Sales $428.00K Miss $500.00K Estimate

2025 Guidance
In December 2024, Pembina announced a 2025 adjusted EBITDA guidance range of $4.2 billion to $4.5 billion, which relative to 2024 reflects the impacts of continued volume growth across the WCSB, new assets acquired or placed into service, and the full year impact of the consolidation of the Alliance and Aux Sable assets, partially offset primarily by the full year impact of the recontracting of the Cochin Pipeline, and normalization of commodity margins in the marketing business.
Despite proposed tariffs on U.S. energy imports, Pembina does not expect any material near-term impacts given the highly contracted, take-or-pay nature of its business.
The 2025 adjusted EBITDA guidance range reflects quarterly seasonality in Pembina's business including:
<ul>
<li>higher contribution from Alliance in the first and fourth quarters due to the ability to transport higher volumes during colder periods;</li>
<li>higher integrity and geotechnical costs on the conventional pipeline assets in the third and fourth quarters; and</li>
<li>stronger first and fourth quarter results in the NGL marketing business.</li>
</ul>
Pembina continues to execute its strategy within a fully funded model and consistent with its financial guardrails. At December 31, 2024, the ratio of proportionately consolidated debt-to-adjusted EBITDA on a trailing twelve-month basis was 3.5 times, at the low end of the Company's targeted range, and reflecting only three quarters of contribution from the Alliance/Aux Sable Acquisition. Within the 2025 adjusted EBITDA guidance range, Pembina expects to generate positive free cash flow, with all 2025 capital investment program scenarios being fully funded by cash flow from operating activities, net of dividends. Further, the Company is forecasting a year-end 2025 proportionately consolidated debt-to-adjusted EBITDA ratio of 3.3 to 3.6 times.

Pembina Pipeline Sees FY25 Adj. EBITDA C$4.2B-C$4.5B

MasTec (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTZ#NYSE">MTZ</a>) reported quarterly earnings of $1.44 per share which beat the analyst consensus estimate of $1.23 by 17.07 percent. This is a 118.18 percent increase over earnings of $0.66 per share from the same period last year. The company reported quarterly sales of $3.40 billion which beat the analyst consensus estimate of $3.32 billion by 2.57 percent. This is a 3.75 percent increase over sales of $3.28 billion the same period last year.

MasTec Q4 2024 Adj EPS $1.44 Beats $1.23 Estimate, Sales $3.40B Beat $3.32B Estimate

Pembina Pipeline Q4 2024 GAAP EPS C$0.92 Beats C$0.82 Estimate, Sales C$2.145B Beats C$2.053B Estimate

It anticipates incurring total pre-tax restructuring charges of approximately $135 million to $150 million, a substantial majority of which would result in cash expenditures.&nbsp;

ADSK

Autodesk To Terminate Approximately 9% Of Its Workforce, Or Approximately 1,350 Employees

Bain Capital Specialty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BCSF#NYSE">BCSF</a>) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.48 by 8.33 percent. This is a 3.7 percent decrease over earnings of $0.54 per share from the same period last year. The company reported quarterly sales of $73.30 million which beat the analyst consensus estimate of $69.24 million by 5.87 percent. This is a 2.20 percent decrease over sales of $74.95 million the same period last year.

BCSF

Bain Capital Specialty Q4 GAAP EPS $0.52 Beats $0.48 Estimate, Sales $73.30M Beat $69.24M Estimate

American Healthcares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHR#NYSE">AHR</a>) is looking for FY2025 FFO of $1.56-$1.60 vs $1.59 analyst estimate..

Comments

Crystal International Gr

Crystal International Gr (CRYIF) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO